GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lianluo Smart Ltd (NAS:LLIT) » Definitions » EV-to-EBIT

Lianluo Smart (Lianluo Smart) EV-to-EBIT : -14.94 (As of Apr. 28, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Lianluo Smart EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Lianluo Smart's Enterprise Value is $44.45 Mil. Lianluo Smart's EBIT for the trailing twelve months (TTM) ended in Dec. 2020 was $-2.98 Mil. Therefore, Lianluo Smart's EV-to-EBIT for today is -14.94.

The historical rank and industry rank for Lianluo Smart's EV-to-EBIT or its related term are showing as below:

LLIT' s EV-to-EBIT Range Over the Past 10 Years
Min: -37.36   Med: 0.05   Max: 2.98
Current: -14.22

During the past 13 years, the highest EV-to-EBIT of Lianluo Smart was 2.98. The lowest was -37.36. And the median was 0.05.

LLIT's EV-to-EBIT is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 19.9 vs LLIT: -14.22

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Lianluo Smart's Enterprise Value for the quarter that ended in Dec. 2020 was $14.63 Mil. Lianluo Smart's EBIT for the trailing twelve months (TTM) ended in Dec. 2020 was $-2.98 Mil. Lianluo Smart's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2020 was -20.33%.


Lianluo Smart EV-to-EBIT Historical Data

The historical data trend for Lianluo Smart's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lianluo Smart EV-to-EBIT Chart

Lianluo Smart Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.85 -4.59 -4.16 -2.54 -4.93

Lianluo Smart Semi-Annual Data
Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.16 - -2.54 - -4.93

Competitive Comparison of Lianluo Smart's EV-to-EBIT

For the Medical Devices subindustry, Lianluo Smart's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lianluo Smart's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lianluo Smart's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Lianluo Smart's EV-to-EBIT falls into.



Lianluo Smart EV-to-EBIT Calculation

Lianluo Smart's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=44.453/-2.975
=-14.94

Lianluo Smart's current Enterprise Value is $44.45 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lianluo Smart's EBIT for the trailing twelve months (TTM) ended in Dec. 2020 was $-2.98 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lianluo Smart  (NAS:LLIT) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Lianluo Smart's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2020 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2020 ) =EBIT / Enterprise Value (Q: Dec. 2020 )
=-2.975/14.6322155
=-20.33 %

Lianluo Smart's Enterprise Value for the quarter that ended in Dec. 2020 was $14.63 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lianluo Smart's EBIT for the trailing twelve months (TTM) ended in Dec. 2020 was $-2.98 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lianluo Smart EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Lianluo Smart's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Lianluo Smart (Lianluo Smart) Business Description

Traded in Other Exchanges
N/A
Address
No. 10 Baifuquan Roa, Room 611, 6th Floor, BeiKong Technology Building, Changping District, Beijing, CHN, 102200
Lianluo Smart Ltd design, develop and market medical products and medical components. The company focuses on the business sectors of; Medical Equipment and the provision of Obstructive Sleep Apnea Syndrome (OSAS) diagnostic services. Its products include wearable sleep respiratory devices, medical devices for cardiopulmonary resuscitation, DHR998 Plus, and others. The company sells its products to distributors, hospitals and physical examination centers, and others. All of its revenue is generated from China.